minutely increased on T1-and T2-weighted sequences," which "may reflect underlying pigment/mineral deposition." Magnetic resonance imaging at month 20 ( Figure 1B and D) reported mild atrophy and mild small vessel disease. There was no change in the slight bilateral striatal T2-weighted hyperintensity.
Clinical Discussion (Dr Perry) This patient's clinical course is characterized by an uncertain time of onset, with 2 years of nonprogressive, potentially related symptoms, including depression, a single fall, and dry cough with hoarseness. This was followed by a progressive neurological decline over 2 years involving multiple systems, with evidence of extrapyramidal, pyramidal, oculomotor, cognitive, and behavioral features. In evaluating patients who present late in their course with the involvement of multiple neurological systems and significant impairment, it is helpful to revisit the first symptoms, as neurodegenerative diseases often begin preferentially in a small number of regions. With the addition of more symptoms and an understanding of the progression rate, the clinician attempts to recognize known syndromes and looks for individual features with sufficient specificity to narrow the diagnostic possibilities. This patient's first symptoms were nonspecific. Depression can be the first manifestation of many neurodegenerative diseases. The presence of extrapyramidal, myoclonic, cognitive, and behavioral features suggests a more limited set of possibilities, with dementia with Lewy bodies being the most common. She had features, however, that made this unlikely, including eye movement abnormalities and early falls, which may indicate progressive supranuclear palsy (PSP). She met the diagnostic inclusion criteria for probable PSP, including an age of 40 years or older at onset, progressive disorder with early vertical supranuclear gaze palsy, and prominent postural instability with falls in the first year of onset. She also met supportive criteria, including symmetric akinesia, levodopa nonresponsive parkinsonism, early cognitive impairment, apathy, and dysphagia. 1 The MRI striatal hyperintensity, downplayed by the radiological interpretation, however, might qualify as a relevant basal ganglia "structural" abnormality, which is an exclusion criterion for a PSP diagnosis. 1 In addition, some of the patient's other features were atypical for PSP, including myoclonus, asymmetry, and no axial rigidity. Her disease duration was shorter than the average 5 to 7 years seen in PSP, although more rapid cases have been described. 2 Corticobasal degeneration could also explain the patient's atypical parkinsonism, lack of levodopa responsiveness, myoclonus, and cognitive and behavioral features, but it would not be expected to cause her oculomotor findings until a late stage. Saccadic eye movement abnormalities have also been described in motor neuron disease (she had no lower motor neuron findings), multiple system atrophy, and spinocerebellar ataxia (she had no family history or cerebellar findings). A PSP syndrome has been described with some DCTN1 mutations, but again, she lacked a relevant family history. Vertical supranuclear gaze palsy, movement disorders, and cognitive and psychiatric symptoms are seen in late-onset Niemann-Pick C disease, though what is considered late for that illness would still be much earlier than this patient's age at onset. Wilson disease rarely occurs after age 70 years and can cause vertical eye movement abnormalities and parkinsonism, but she had negative copper and ceruloplasmin test results, making this less likely. Whipple disease can cause parkinsonism and vertical ophthalmoplegia, and though she had no gastrointestinal symptoms, a minority of cases have isolated central nervous system involvement.
Her MRI most strongly raises concern for prion disease, with striatal and cingulate hyperintensities more prominent on diffusionweighted-imaging than on fluid-attenuated inversion recovery. 3 Restricted diffusion in the striatum and cortex (cortical ribboning) on diffusion-weighted imaging is among the most sensitive and specific antemortem tests for detecting Jakob-Creutzfeldt Disease (JCD) with a diagnostic accuracy of 97%. 3 A 4-year time course would be longer than expected for JCD, and vertical gaze palsy with slowed saccadic velocity is not typically described. Prion disease, however, can present in numerous ways 4 and would explain her relatively rapid progression, myoclonus, parkinsonism, and cognitive impairment.
Neuropathological Discussion (Drs Grinberg and DeArmond) A brain pathological assessment was performed at the University of California, San Francisco/Memory and Aging Center Neurodegenerative Disease Brain Bank and the National Prion Disease Pathology Surveillance Center. Postmortem delay was 12 hours and the brain weighed 1079 g. A gross examination revealed general atrophy and ventriculomegaly with substantia nigra pigment loss, mildly thinned cortical ribbon, and a normal size midbrain. Microscopy showed extensive cortical vacuolation prominent in the deep layers, with colocalized astrogliosis and neuronal loss. Vacuolation also involved striatum and dentate nucleus of the cerebellum, but was mild in the hippocampus and was not present in the occipital cortex and cerebellar molecular layer. The substantia nigra showed a moderate loss of neuromelanin. β-Amyloid and phospho-tau immunostaining revealed low Alzheimer disease neuropathologic changes (National Institute on Aging-Alzheimer's Association A1B1C0). Transactive response deoxyribonucleic acid binding protein-43 (ie, TDP-43) and fused in sarcoma (ie, FUS) staining were negative. Immunostaining using the anti-prion protein (PrP) antibody 3F4 showed diffuse or "synaptic" PrP Sc in most brain regions and no plaques. Molecular and genetic analyses showed type 1 prion, no mutation in the prion protein gene, and codon 129 polymorphism methionine-valine (ie, sJCDMV1) subtype 5 but with atypical predominance of unglycosylated PK-resistant PrP Sc (US National Prion Disease Pathology Surveillance Center) ( Figure 2) . Interestingly, her cerebrospinal fluid research test results, which returned post mortem, revealed normal total and phospho-tau levels, but novel biomarkers (N-terminal and central epitopes of the tau protein [BT2 + HT7; HT7 + Tau5]) as well as the neurofilament light chain were 9 to 19 times higher than typical for PSP, 6,7 which additionally would have suggested against a PSP diagnosis.
Conclusions
Although classical sporadic JCD (sJCD) involves rapid dementia with ataxia and myoclonus, sJCD has a variable semiology and duration and is commonly misdiagnosed. 4 A recent study showed that sJCD patients had almost 4 misdiagnoses before correctly being diagnosed, including atypical parkinsonian syndromes (4%), but none with PSP. 4 Although the initial criteria for "probable PSP" were . Lanes 3 to 5 were rerun with less BH than lanes 6 to 8, and lanes 3 to 4 clearly show the predominance of unglycosylated resPrP Sc , which is atypical for MV1. Scale bars: A, B, and E: 500 μm; C, D, and G: 50 μm; F: 100 μm; H: 1 cm. DN indicates dentate nucleus; GL, granular layer; IC, inner cortical layers; ML, molecular layer; OC, outer cortical layers; PAG, periaqueductal gray; PrPSc, prions; SC, superior colliculus; SN, substantia nigra; u, unglycosylated; WM, white matter. The median life expectancy for patients is about 5 months in the sJCD MV1 subtype, but with a wide range (1-54 months) . 9 Most other sJCD subtypes have median durations of about 1 year, with similarly large ranges. 9 In this patient, it was difficult to determine the onset of symptoms because she was relatively stable for 2 years after her first fall, but her disease duration was at least 28 months from the onset of progressive neurological decline, which is within the range reported previously. 9 Besides walking difficulty and instability, eye movement abnormalities can also lead to misdiagnosing JCD as PSP. Unfortunately, most prion disease cohort studies report oculomotor and visual symptoms as a combined category, making it difficult to study the true frequency of each. Oculomotor problems in sJCD and genetic prion disease have been reported, however, in case reports. 10 In this case, early vision complaints but late oculomotor problems could be consistent with JCD. 10 The late oculomotor problems were not as consistent with PSP, however.
1,8
Ancillary test results might have been useful to diagnose JCD. The patient's 14-month sagittal MRIs suggested rostral midbrain atrophy, a signal sometimes helpful in differentiating PSP from PD or multiple system atrophy, 11 but the striatal and subtle diffusionweighted imaging cortical ribboning hyperintensities should have raised suspicion for JCD. Unfortunately, sJCD MRIs are often misread. 3 Cerebrospinal fluid proteins (14-3-3, neuron-specific enolase, and total-tau) have moderate diagnostic utility, although their absence does not exclude JCD. 3 Sc deposition usually involves all cerebral cortex layers plus neostriatum, thalamus, and cerebellum, sparing hippocampus and brainstem nuclei. 5 In this case, vacuolation showed a laminar pattern affecting mostly the inner cortical layers. Moreover, the midbrain was severely involved and the molecular layer of the cerebellum and occipital cortex were spared, unlike sJCD MV1. The substantia nigra involvement explains the profound parkinsonism. Some of the histopathological features of this case are reminiscent of sJCD MV2 and VV2 subtypes, although PrP Sc plaques are missing. 5 A Western blot showed PrP Sc type 1, but with an atypical ratio of di, mono, and unglycosylated PrP Sc isoforms that was at variance with sJCDMV1 subtype (as well as other sJCD subtypes) 5 and resembling an atypical PrP Sc prior case report.
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Sporadic JCD, even MV1 subtypes, can have clinically atypical presentations, including PSP-like presentations, with a disease duration of more than 2 years. In this case, the presence of myoclonus, asymmetric features, a relatively rapid course, and the MRI findings should have suggested against PSP and raised suspicion for JCD. Had her MRI been interpreted properly, she might have been diagnosed correctly ante mortem. A careful read of a diffusionweighted imaging/apparent diffusion coefficient MRI is essential in cases of atypical neurodegenerative diseases, particularly with unusually rapid presentations. In this case, cerebrospinal fluid was distributed to several research centers, and most disturbingly, the neuropathology laboratory personnel and equipment were unnecessarily exposed to PrP
Sc . An early and accurate diagnosis of sJCD is extremely important for infection control and prognostic reasons.
